You are here

PolyPid

Crushed by PhIII antibiotic flop, PolyPid says it got FDA support for a comeback — by focusing on subgroup

Endpoints

Tue, 01/24/23 - 06:07 pm

clinical trials

PolyPid Shares Fall on Abdominal-Surgery-Treatment-Trial Results

Marketwatch

Fri, 09/2/22 - 12:26 pm

clinical trials

surgical site infections

What pandemic? Biotech floats break records

EP Vantage

Wed, 07/8/20 - 10:37 am

ADC Therapeutics

Applied Molecular Transport

Avidity Biosciences

Ayala Pharmaceuticals

Forma Therapeutics

Fusion Pharmaceuticals

Hyloris Pharmaceuticals

ORIC Pharmaceuticals

Pliant Therapeutics

Repare Therapeutics

Nasdaq Sees Israeli Biotech IPOs Tapping the Market This Year

Bloomberg

Sun, 05/22/16 - 11:41 am